Dr Gregory Rice is an internationally recognised academic and commercial scientist with over 30 years of experience in oncology, perinatology, exosome-based research, clinical translational research, IVD development and commercialisation.
He held senior academic appointments, co-founded hospital-based clinical research centres in oncology and perinatology, and co-founded & led diagnostic companies.
Dr Rice has significant research and commercialisation experience focused on the identification and validation of disease biomarkers, and development of In Vitro Diagnostic Multivariate Index Assays (IVDMIAs) for ovarian cancer and obstetrical syndromes, and their translation into clinical applications. He has successfully delivered diagnostic products from concept-to-market.
Dr Rice is also an award-winning scientist, has published more than 280 peer-reviewed scientific publications, and is a regular speaker at international conferences.
He holds a Doctor of Philosophy and Bachelor of Science (First Class Honours) from the University of Western Australia, and a Graduate Diploma in Management and Master of Health Administration from RMIT University.
